BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 25833732)

  • 1. Latent change score modeling as a method for analyzing the antidepressant effect of a psychosocial intervention in Alzheimer's disease.
    Werheid K; Köhncke Y; Ziegler M; Kurz A
    Psychother Psychosom; 2015; 84(3):159-66. PubMed ID: 25833732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial.
    Kurz A; Thöne-Otto A; Cramer B; Egert S; Frölich L; Gertz HJ; Kehl V; Wagenpfeil S; Werheid K
    Alzheimer Dis Assoc Disord; 2012; 26(3):246-53. PubMed ID: 21986341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?
    Mossello E; Boncinelli M; Caleri V; Cavallini MC; Palermo E; Di Bari M; Tilli S; Sarcone E; Simoni D; Biagini CA; Masotti G; Marchionni N
    Dement Geriatr Cogn Disord; 2008; 25(4):372-9. PubMed ID: 18354253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
    King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
    Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Latent growth curve modeling for improvement of clinical symptoms on depression].
    Li LX; Zhang YB; Gao YH; Zhang M; Zhou S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Aug; 34(8):832-5. PubMed ID: 24423774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial.
    Rolland Y; Pillard F; Klapouszczak A; Reynish E; Thomas D; Andrieu S; Rivière D; Vellas B
    J Am Geriatr Soc; 2007 Feb; 55(2):158-65. PubMed ID: 17302650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study.
    Fritze F; Ehrt U; Hortobagyi T; Ballard C; Aarsland D
    Dement Geriatr Cogn Disord; 2011; 32(2):143-9. PubMed ID: 21986003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomized controlled trial of a brief early intervention for reducing posttraumatic stress disorder, anxiety and depressive symptoms in newly diagnosed head and neck cancer patients.
    Kangas M; Milross C; Taylor A; Bryant RA
    Psychooncology; 2013 Jul; 22(7):1665-73. PubMed ID: 23042612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions.
    Clare L; Wilson BA; Carter G; Breen K; Berrios GE; Hodges JR
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):962-7. PubMed ID: 12325058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease and depression].
    Mizukami K
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1122-6. PubMed ID: 24450144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status.
    Holtzer R; Scarmeas N; Wegesin DJ; Albert M; Brandt J; Dubois B; Hadjigeorgiou GM; Stern Y
    J Am Geriatr Soc; 2005 Dec; 53(12):2083-9. PubMed ID: 16398891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do changes in specific cognitive functions predict changes in health-related quality of life in people with Alzheimer's disease?
    Bosboom PR; Almeida OP
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):694-703. PubMed ID: 24273030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD.
    Albus C; Beutel ME; Deter HC; Fritzsche K; Hellmich M; Jordan J; Juenger J; Krauth C; Ladwig KH; Michal M; Mueck-Weymann M; Petrowski K; Pieske B; Ronel J; Soellner W; Waller C; Weber C; Herrmann-Lingen C
    J Psychosom Res; 2011 Oct; 71(4):215-22. PubMed ID: 21911098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualifying change: a method for defining clinically meaningful outcomes of change score computation.
    Tractenberg RE; Jin S; Patterson M; Schneider LS; Gamst A; Thomas RG; Thal LJ
    J Am Geriatr Soc; 2000 Nov; 48(11):1478-82. PubMed ID: 11083327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.